Optimal control strategy for cancer remission using combinatorial therapy: A mathematical model-based approach

Parthasakha Das, Samhita Das, Pritha Das, Fathalla A A. Rihan, Muhammet Uzuntarla, Dibakar Ghosh

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

In this article, we develop and analyze a non-linear mathematical model of tumor-immune interactions with combined therapeutic drug and treatment controls. To understand under what circumstances the cancerous cells can be destroyed, an optimal control problem is formulated with treatments as control parameters. By designing a quadratic control based functional, we establish the optimal treatment strategies that maximize the number of immune-effector cells, minimize the number of cancer cells, and detrimental effects caused by the amount of drugs. The necessary and sufficient conditions for optimal control are established. We prove the existence and uniqueness of an optimal control problem. To recognize significant system's parameters, sensitivity analysis are performed for the drug administration and cost functional respectively. We also carry out a cost-effectiveness analysis to determine the most cost-effective therapeutic strategy. The numerical results validate analytical findings and also elucidates that the combinatorial drug therapy can alleviate the cancerous cells under different scenarios.

Original languageEnglish
Article number110789
JournalChaos, Solitons and Fractals
Volume145
DOIs
Publication statusPublished - Apr 2021

Keywords

  • Cost-effectiveness analysis
  • Immuno-chemotherapy
  • Pontryagin's maximum principle
  • Sensitivity analysis
  • Tumor model

ASJC Scopus subject areas

  • Statistical and Nonlinear Physics
  • Mathematics(all)
  • Physics and Astronomy(all)
  • Applied Mathematics

Fingerprint

Dive into the research topics of 'Optimal control strategy for cancer remission using combinatorial therapy: A mathematical model-based approach'. Together they form a unique fingerprint.

Cite this